NCT01900379View on ClinicalTrials.gov

PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Heart FailureArteriosclerosis of Coronary Artery Bypass Graft or Other Coronary ReperfusionSleep Apnea, Obstructive
Interventions
PROCEDURE

CPAP treatment

This device consists in a nasal continuous positive airway pressure. It will be applied just after CABG and for 3 months for OSA/CPAP patients group.

OTHER

Sham CPAP treatment

This device consists in a sham continuous positive airway pressure. It will be applied just after CABG and for 3 months for OSA/sham CPAP patients group.

Trial Locations (1)

38000

University Hospital of Grenoble, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT01900379 - PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function | Biotech Hunter | Biotech Hunter